Sun Pharmaceutical Industries Ltd has inked definitive agreements to acquire 85.1% stake in Russian company, JSC Biosintez, for $24 million, a move aimed at increasing presence in Russia through local manufacturing capability.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
